AXGN
Price
$16.27
Change
-$0.24 (-1.45%)
Updated
Apr 30, 04:59 PM (EDT)
Capitalization
348.67M
8 days until earnings call
SERA
Price
$2.92
Change
-$0.06 (-2.01%)
Updated
Apr 30, 04:59 PM (EDT)
Capitalization
303.83M
6 days until earnings call
Ad is loading...

AXGN vs SERA

Header iconAXGN vs SERA Comparison
Open Charts AXGN vs SERABanner chart's image
Axogen
Price$16.27
Change-$0.24 (-1.45%)
Volume$7.22K
Capitalization348.67M
Sera Prognostics
Price$2.92
Change-$0.06 (-2.01%)
Volume$592
Capitalization303.83M
AXGN vs SERA Comparison Chart
Loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXGN vs. SERA commentary
May 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXGN is a Buy and SERA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 01, 2025
Stock price -- (AXGN: $16.51 vs. SERA: $2.98)
Brand notoriety: AXGN and SERA are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AXGN: 37% vs. SERA: 152%
Market capitalization -- AXGN: $348.67M vs. SERA: $303.83M
AXGN [@Medical Specialties] is valued at $348.67M. SERA’s [@Medical Specialties] market capitalization is $303.83M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXGN’s FA Score shows that 0 FA rating(s) are green whileSERA’s FA Score has 0 green FA rating(s).

  • AXGN’s FA Score: 0 green, 5 red.
  • SERA’s FA Score: 0 green, 5 red.
According to our system of comparison, AXGN is a better buy in the long-term than SERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXGN’s TA Score shows that 5 TA indicator(s) are bullish while SERA’s TA Score has 5 bullish TA indicator(s).

  • AXGN’s TA Score: 5 bullish, 5 bearish.
  • SERA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SERA is a better buy in the short-term than AXGN.

Price Growth

AXGN (@Medical Specialties) experienced а +7.00% price change this week, while SERA (@Medical Specialties) price change was -14.37% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.73%. For the same industry, the average monthly price growth was -1.71%, and the average quarterly price growth was -2.72%.

Reported Earning Dates

AXGN is expected to report earnings on Aug 06, 2025.

SERA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+2.73% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXGN($349M) has a higher market cap than SERA($304M). AXGN YTD gains are higher at: 0.182 vs. SERA (-63.391). AXGN has higher annual earnings (EBITDA): -13.33M vs. SERA (-35.29M). SERA has more cash in the bank: 49.1M vs. AXGN (31M). SERA has less debt than AXGN: SERA (1.86M) vs AXGN (69.3M). AXGN has higher revenues than SERA: AXGN (159M) vs SERA (306K).
AXGNSERAAXGN / SERA
Capitalization349M304M115%
EBITDA-13.33M-35.29M38%
Gain YTD0.182-63.391-0%
P/E RatioN/AN/A-
Revenue159M306K51,961%
Total Cash31M49.1M63%
Total Debt69.3M1.86M3,730%
FUNDAMENTALS RATINGS
AXGN: Fundamental Ratings
AXGN
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXGNSERA
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMMEX15.21N/A
N/A
Northern Active M Emerging Market Equity
LMGCX13.13N/A
N/A
Lord Abbett Growth Opportunities C
SMVTX11.18N/A
N/A
Virtus Ceredex Mid-Cap Value Equity I
FAPHX12.45N/A
N/A
Fidelity Healthy Future
VGELX86.03N/A
N/A
Vanguard Energy Adm

AXGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with TCMD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
+2.04%
TCMD - AXGN
43%
Loosely correlated
+0.35%
TMDX - AXGN
38%
Loosely correlated
+2.48%
ICUI - AXGN
38%
Loosely correlated
+1.01%
XRAY - AXGN
36%
Loosely correlated
+0.58%
CLPT - AXGN
36%
Loosely correlated
-0.27%
More

SERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SERA has been loosely correlated with SGHT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SERA jumps, then SGHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SERA
1D Price
Change %
SERA100%
-0.67%
SGHT - SERA
38%
Loosely correlated
+1.94%
XRAY - SERA
32%
Poorly correlated
+0.58%
ANGO - SERA
30%
Poorly correlated
+0.63%
AXGN - SERA
29%
Poorly correlated
+2.04%
QTRX - SERA
29%
Poorly correlated
+4.67%
More